Advaxis: Of The Original Form 8k To Provide The Pro Forma Financial Information Required Under Item 9.01(b) Of Form 8k, Which Ayala Was Not Able To Complete Until It Filed Its Annual Report On Form 10k For The Year Ended December 31, 2023, Which It Did On April 16, 2024

Show full article

This functionality is available for registred users only

• Full name
  Advaxis, Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***